| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 53.99▼ | 54.10▼ | 54.08▼ | 56.96▼ | 58.54▼ |
| MA10 | 54.02▼ | 54.05▼ | 54.92▼ | 57.51▼ | 56.99▼ |
| MA20 | 54.10▼ | 55.08▼ | 56.35▼ | 59.33▼ | 42.00▲ |
| MA50 | 54.04▼ | 56.55▼ | 56.23▼ | 56.54▼ | 24.29▲ |
| MA100 | 54.98▼ | 56.25▼ | 58.61▼ | 41.06▲ | 20.62▲ |
| MA200 | 56.39▼ | 58.83▼ | 58.44▼ | 26.08▲ | 32.64▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.014▼ | -0.023▼ | -0.335▼ | -0.888▼ | 0.905▲ |
| RSI | 47.590▼ | 40.739▼ | 40.613▼ | 44.176▼ | 64.965▲ |
| STOCH | 59.532 | 43.848 | 19.483▼ | 24.115 | 72.806 |
| WILL %R | -47.656 | -79.645▼ | -84.274▼ | -92.379▼ | -29.055 |
| CCI | -74.655 | -35.108 | -66.773 | -113.560▼ | 35.303 |
|
Wednesday, November 12, 2025 06:59 AM
Nektar Therapeutics develops novel immunomodulatory drugs targeting autoimmune diseases and oncology. Click here to read why NKTR stock is a Buy.
|
|
Tuesday, November 11, 2025 08:39 PM
Nektar Therapeutics has pivoted from oncology to focus on autoimmune and inflammatory diseases. Read why I rate NKTR stock a Buy now.
|
|
Monday, November 10, 2025 07:34 AM
Nektar Therapeutics (NASDAQ:NKTR) shares climbed 3.6% on Monday after the biotech firm unveiled encouraging new data showing that its experimental therapy rezpegaldesleukin improved asthma symptoms in ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/11/25 | 55.90 | 55.90 | 52.88 | 53.95 | 771,753 |
| 12/11/25 | 58.71 | 59.18 | 56.25 | 57.67 | 699,389 |
| 11/11/25 | 57.01 | 59.38 | 56.695 | 59.26 | 716,798 |
| 10/11/25 | 56.72 | 58.61 | 54.59 | 57.97 | 687,438 |
| 07/11/25 | 56.00 | 57.99 | 55.01 | 55.97 | 859,385 |
| 06/11/25 | 54.05 | 57.41 | 53.60 | 55.12 | 883,952 |
| 05/11/25 | 55.99 | 57.02 | 53.91 | 54.26 | 685,786 |
| 04/11/25 | 57.11 | 58.51 | 55.70 | 56.02 | 706,156 |
| 03/11/25 | 62.40 | 63.99 | 57.33 | 59.92 | 954,400 |
| 31/10/25 | 62.79 | 66.92 | 61.50 | 64.93 | 769,340 |
|
|
||||
|
|
||||
|
|